(Credit: © NRoytman Photography - stock.adobe.com)
In A Nutshell
- The American Heart Association says moderate coffee intake, up to about 400 milligrams of caffeine a day or roughly 3 to 5 cups, is safe for most adults.
- A randomized trial found coffee drinkers with atrial fibrillation who kept drinking coffee had a 39% lower risk of the condition coming back after treatment.
- Moderate coffee intake was linked to a 21% lower stroke risk and up to a 30% lower risk of type 2 diabetes in large reviews.
- Energy drinks and high-dose caffeine capsules are a different story, with limited evidence pointing toward real cardiovascular harm.
Five cups of coffee a day sounds like a lot. According to the American Heart Association, it’s still within the safe zone for most adults.
A new scientific statement from the group, published in the journal Circulation, concludes that moderate coffee consumption, up to about 400 milligrams of caffeine daily, is safe for most people and is associated with a lower risk of several serious heart conditions. That works out to roughly 3 to 5 standard 8-ounce cups, depending on how the coffee is brewed.
The review draws on decades of research covering caffeine’s effects on blood pressure, blood sugar, cholesterol, and heart health more broadly. While most of the underlying evidence is observational, meaning it shows associations rather than proof that coffee itself causes the benefit, the overall picture is consistently favorable for moderate drinkers.
Coffee Cuts the Risk of Irregular Heartbeat Coming Back
One of the more surprising findings involves atrial fibrillation, an irregular heartbeat that affects millions of Americans and raises the risk of stroke. People with atrial fibrillation have often been advised to avoid caffeine, but newer evidence has challenged that assumption. In a randomized trial of coffee drinkers with atrial fibrillation who were scheduled for a procedure to restore normal rhythm, those assigned to drink at least one cup of caffeinated coffee a day had a 39% lower risk of recurrence than those assigned to avoid coffee and caffeine. Updated ACC/AHA/HRS guidelines now advise clinicians not to recommend avoiding caffeine to reduce atrial fibrillation risk.
Stroke data point in a similarly reassuring direction. A review of 20 large studies found the lowest stroke risk at moderate coffee intake of 3 to 4 cups per day, a 21% reduction compared with lower intake.
Coffee’s relationship with type 2 diabetes also caught researchers’ attention. A review of 28 large studies found a 20% lower risk of diabetes among people who averaged about 3.5 cups per day, and a 30% lower risk among those who averaged 5 cups per day. For heart failure, the condition where the heart can no longer pump blood effectively enough to meet the body’s needs, several large studies found either no increased risk or a modestly lower risk among regular coffee drinkers, with roughly 4 cups per day tied to the lowest risk.

Cholesterol Rises With Unfiltered Coffee, Not the Filtered Kind
Coffee contains hundreds of other biologically active compounds, and experimental studies suggest it has antioxidant and anti-inflammatory properties. Decaffeinated coffee shows some favorable associations too, suggesting caffeine is only part of what may make coffee beneficial, though researchers have not pinned down which compounds drive which effects.
Energy drinks get more cautious treatment than coffee and tea in the statement. Although the evidence is limited, available research generally points toward cardiovascular harm. Energy drinks can contain extremely high concentrations of caffeine alongside ingredients like taurine that speed how quickly caffeine enters the bloodstream, and multiple case reports have linked them to serious heart rhythm problems, even in otherwise healthy young people. High-dose caffeine in capsule or powder form, more than 10 times the amount in a typical cup of coffee, has been linked in case reports to life-threatening heart events.
Brewing method matters too. Unfiltered coffee, including French press and Turkish coffee, leaves in a compound called cafestol, which raises LDL cholesterol, the kind associated with heart disease. Paper-filtered and instant coffee don’t carry the same concern. And the potential benefits apply to coffee itself, not necessarily heavily sweetened coffee drinks. The AHA notes that large amounts of sugar, syrups, and high-calorie dairy additions may offset those advantages.
Genetics Explain Why Caffeine Hits Some People Harder Than Others
Caffeine and blood pressure have a more tangled relationship. In the short term, caffeine can cause a temporary spike in blood pressure, an effect that appears stronger in people who already have high blood pressure. For habitual drinkers, any long-term effect is likely modest for most people, though the evidence doesn’t yet support firm conclusions. Risk may be greater at high intakes, particularly for people with severe hypertension or a strong sensitivity to caffeine.
Genetics play a real role here. The estimated genetic influence on how much caffeine a person consumes and how they respond to it ranges from 30% to more than 50%, which may help explain why one person can drink several cups with little trouble while another feels jittery after much less. Pregnancy also slows caffeine metabolism considerably.
Still, after reviewing decades of data across multiple study types, including a growing number of controlled trials, the AHA concludes that moderate coffee consumption can be part of a healthy lifestyle for most adults. One caveat runs through nearly every finding above: people who drink coffee in moderation may also tend to make healthier choices overall, a pattern researchers call “healthy user bias,” which makes it hard to know how much of the benefit comes from the coffee itself. Even so, for the millions of Americans who start every day with a cup or two, that’s a finding worth savoring.
Disclaimer: This article is based on a scientific statement from the American Heart Association and is intended for general informational purposes only. It is not medical advice. Anyone with heart rhythm problems, high blood pressure, or other cardiovascular conditions should talk with a doctor before making changes to caffeine or coffee intake.
Paper Notes
Limitations
The authors acknowledge several important limitations throughout the statement. The vast majority of studies reviewed were observational, making it difficult to establish that caffeine directly causes the health outcomes observed. Most research focused on coffee as a beverage rather than isolated caffeine, making it hard to separate the effects of caffeine from those of other compounds in coffee. Studies also varied widely in how they measured caffeine intake and cardiovascular outcomes, and many relied on participants self-reporting how much they drank. The statement notes that “healthy user bias,” where moderate coffee drinkers may simply be healthier in other ways, could inflate apparent benefits. Research on energy drinks remains limited, and most heart failure studies relied on administrative health records rather than direct clinical measurements, limiting the ability to distinguish between different types of heart failure. The long-term effects of habitual caffeine on blood pressure remain unclear, and clinical trial data on caffeine and blood sugar are inconsistent.
Funding and Disclosures
This statement was produced by the American Heart Association. Writing group member Dr. Frank B. Hu reported a significant relationship with Analysis Group. Writing group member Dr. Marilyn C. Cornelis reported a modest unpaid relationship with the Institute for the Advancement of Food and Nutrition Sciences Caffeine Working Group. Writing group member Dr. Thomas A. Dewland reported a significant consulting relationship with Boston Scientific Corp. Reviewer Dr. Christopher X. Wong reported a significant research grant from the National Health and Medical Research Council of Australia. All other writing group members and reviewers reported no relevant relationships.
Publication Details
Paper Title: Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association | Authors: Gregory M. Marcus, MD, MAS, FAHA (Chair); Frank B. Hu, MD, MPH, PhD, FAHA (Vice Chair); Rob M. van Dam, PhD; Marilyn C. Cornelis, PhD; Thomas A. Dewland, MD; JungHee Kang, PhD, MPH, RN; Susanna C. Larsson, PhD; Robert L. Page II, PharmD, MSPH, FAHA; Niyati Parekh, PhD, FAHA; on behalf of the American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; and Stroke Council. | Journal: Circulation (American Heart Association) | DOI: 10.1161/CIR.0000000000001454 | Statement Approval: Approved by the American Heart Association Science Advisory and Coordinating Committee on March 27, 2026, and by the American Heart Association Executive Committee on May 28, 2026.







